Principal Securities, Inc. Corcept Therapeutics Inc Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 1,932 shares of CORT stock, worth $142,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,932
Previous 1,243
55.43%
Holding current value
$142,890
Previous $62.6 Million
126.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
468Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$716 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$571 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$463 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$286 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...